Chemopreventive and chemotherapeutic potential of curcumin in breast cancer
D Sinha, J Biswas, B Sung, BB Aggarwal… - Current drug …, 2012 - ingentaconnect.com
Breast cancer remains the leading cause of cancer death among females worldwide. It
signifies a shift from the previous decade during which the most common cause of cancer …
signifies a shift from the previous decade during which the most common cause of cancer …
Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs
Background Curcumin inhibits growth of several cancer cell lines, and studies in this
laboratory in bladder and pancreatic cancer cells show that curcumin downregulates …
laboratory in bladder and pancreatic cancer cells show that curcumin downregulates …
Synthesis and evaluation of curcumin-related compounds for anticancer activity
X Wei, ZY Du, X Zheng, XX Cui, AH Conney… - European journal of …, 2012 - Elsevier
Sixty-one curcumin-related compounds were synthesized and evaluated for their anticancer
activity toward cultured prostate cancer PC-3 cells, pancreas cancer Panc-1 cells and colon …
activity toward cultured prostate cancer PC-3 cells, pancreas cancer Panc-1 cells and colon …
Effects of cyclohexanone analogues of curcumin on growth, apoptosis and NF-κB activity in PC-3 human prostate cancer cells
X Wei, ZY Du, XX Cui, M Verano, RQ Mo… - Oncology …, 2012 - spandidos-publications.com
Curcumin is a non-nutritive yellow pigment found in the spice turmeric, which is derived from
the rhizome of the plant Curcuma longa Linn. Six cyclohexanone analogues of curcumin (A1 …
the rhizome of the plant Curcuma longa Linn. Six cyclohexanone analogues of curcumin (A1 …
[HTML][HTML] RL71, a second-generation curcumin analog, induces apoptosis and downregulates Akt in ER-negative breast cancer cells
B Yadav, S Taurin, L Larsen… - … journal of oncology, 2012 - spandidos-publications.com
There is a need for the development of new, safe and efficacious drug therapies for the
treatment of estrogen receptor (ER)-negative breast cancers. RL71 is a second-generation …
treatment of estrogen receptor (ER)-negative breast cancers. RL71 is a second-generation …
RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER‑negative breast cancer models
B Yadav, S Taurin, L Larsen… - … journal of oncology, 2012 - spandidos-publications.com
There is a need for the development of new safe and efficacious drug therapies for the
treatment of estrogen receptor (ER)‑negative breast cancers. 1-Methyl-3, 5-bis [(E)-4-pyridyl) …
treatment of estrogen receptor (ER)‑negative breast cancers. 1-Methyl-3, 5-bis [(E)-4-pyridyl) …
Identification of cyclohexanone derivatives that act as catalytic inhibitors of topoisomerase I: effects on tamoxifen-resistant MCF-7 cancer cells
E Leung, GW Rewcastle, WR Joseph… - Investigational New …, 2012 - Springer
Breast cancer is commonly treated with anti-estrogens or aromatase inhibitors, but resistant
disease eventually develops and new therapies for such resistance are of great interest. We …
disease eventually develops and new therapies for such resistance are of great interest. We …
[HTML][HTML] Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs
Background Curcumin inhibits growth of several cancer cell lines, and studies in this
laboratory in bladder and pancreatic cancer cells show that curcumin downregulates …
laboratory in bladder and pancreatic cancer cells show that curcumin downregulates …
Systhesis, Characterization and Spectroscopic Properties of (2E, 6E)-2, 6-Bis (2, 3, 4-tri-methoxy-benzylidene) cyclohexanone
XC Wei, ZL Liu, K Zhang, ZY Du… - Advanced Materials …, 2012 - Trans Tech Publ
In this paper,(2E, 6E)-2, 6-Bis (2, 3, 4-tri-methoxy-benzylidene) cyclohexanone (omitted as
tmbcho)(1) was obtained by the reaction of acetic acid, tetrahydrofuran, cyclohexanone and …
tmbcho)(1) was obtained by the reaction of acetic acid, tetrahydrofuran, cyclohexanone and …